Definitive Contract HHSO100201100032C

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response has awarded a $9,271,193.00 Firm Fixed Price contract to Vaxart Biosciences Inc. to conduct clinical trial planning activities for a Phase 2b clinical trial comparing Vaxart's XBB vaccine candidate to an mRNA comparator. The trial will evaluate efficacy for symptomatic and asymptomatic disease, systemic and mucosal immune induction, and adverse events. This definitive contract...

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 9 to Vaxa, Inc., a self-certified small disadvantaged business, for $35,440.00. The contract is for diagnostic equipment physics surveys and has an end date of October 31, 2023. Vaxa has previously provided medical physicist services and radiographic equipment inspections to the VA, Defense Health Agency, and Army Medical Command...

This federal contract award is for the delivery of the VAXELIS vaccine, a 0.5ML vaccine vial, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,461.70 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...

The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a $13,978,077.00 Cost Plus Fixed Fee contract to Vaxart Biosciences Inc., a for-profit manufacturer, for the VAXART major program. The definitive contract has a period of performance through September 30, 2018 and is not a set-aside. The contract is for the delivery of products and services, though the original solicitation details are not provided. There is no mention...

The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the Japanese Encephalitis Vaccine (IXIARO). The $237,264.00 contract, which has no set-aside designation, will be performed in Bethesda, Maryland and runs through April 19, 2024. Valneva USA, Inc. is a subsidiary of the specialty vaccine company Valneva SE, which develops and manufactures vaccines to address...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $41,770 firm fixed price delivery order contract to Vaxa, Inc. for diagnostic equipment physics surveys under the DIAGNOSTIC EQUIPMENT PHYSICS SURVEYS IDIQ. The delivery order was awarded on November 1, 2020 with a period of performance through October 31, 2024. No set-aside designation was used for this award. Vaxa, Inc. will provide diagnostic equipment physics surveys to support...

This is a definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to AlphaVax Human Vaccines Inc. for R&D in physical science and exploratory development. The contract has a ceiling value of $16,660,130.44 and an ultimate completion date of August 14, 2012. It was initially awarded on September 26, 2003 and does not have a set-aside designation. AlphaVax Human Vaccines Inc. is a for-profit organization that...

The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization, to provide the IXIARO vaccine. The contract has a potential value of $112,564.50 and a completion date of March 22, 2024. This delivery order is part of Valneva USA's GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). Valneva USA has...

The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) to provide the IXIARO vaccine. The contract has a potential value of $279,075.00 and the period of performance runs through April 30, 2019. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, is the prime contractor and will fulfill the order from its facility in Potomac, Maryland. The contract was...

This federal contract award, with ID SPE2DX15D3006|SPE2DX25F01SJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the VAXELIS vaccine in 0.5 ml vials, with a firm fixed price of $1,906.26 and a completion date of January 16, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC)...